Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth

Scott, E; Hodgson, K; Calle, B; Turner, H; Cheung, K; Bermudez, A; Marques, FJG; Pye, H; Yo, EC; Islam, K; Oo, HZ; McClurg, UL; Wilson, L; Thomas, H; Frame, FM; Orozco-Moreno, M; Bastian, K; Arredondo, HM; Roustan, C; Gray, MA; Kelly, L; Tolson, A; Mellor, E; Hysenaj, G; Goode, EA; Garnham, R; Duxfield, A; Heavey, S; Stopka-Farooqui, U; Haider, A; Freeman, A; Singh, S; Johnston, EW; Punwani, S; Knight, B; McCullagh, P; McGrath, J; Crundwell, M; Harries, L; Bogdan, D; Westaby, D; Fowler, G; Flohr, P; Yuan, W; Sharp, A; de Bono, J; Maitland, NJ; Wisnovsky, S; Bertozzi, CR; Heer, R; Guerrero, RH; Daugaard, M; Leivo, J; Whitaker, H; Pitteri, S; Wang, N; Elliott, DJ; Schumann, B; Munkley, J

Munkley, J (通讯作者),Newcastle Univ, Inst Biosci, Ctr Canc, Newcastle NE1 3BZ, England.

ONCOGENE, 2023; 42 (12): 926

Abstract

Prostate cancer is the most common cancer in men and it is estimated that over 350,000 men worldwide die of prostate cancer every year. There remains ......

Full Text Link